SGH

Sivik Global Healthcare Portfolio holdings

AUM $205M
1-Year Est. Return 28.16%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+28.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$190M
AUM Growth
-$33.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
64
New
Increased
Reduced
Closed

Top Buys

1
+$6.52M
2
+$5.85M
3
+$4.28M
4
ABBV icon
AbbVie
ABBV
+$4.07M
5
ZBH icon
Zimmer Biomet
ZBH
+$3.96M

Top Sells

1
+$8.87M
2
+$6.9M
3
+$6.28M
4
GILD icon
Gilead Sciences
GILD
+$5.54M
5
UHS icon
Universal Health Services
UHS
+$4.41M

Sector Composition

1 Healthcare 86.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZBH icon
26
Zimmer Biomet
ZBH
$17.7B
$3.94M 2.07%
+40,000
WST icon
27
West Pharmaceutical
WST
$18.1B
$3.94M 2.07%
15,000
DGX icon
28
Quest Diagnostics
DGX
$21.5B
$3.81M 2%
20,000
-5,000
RGEN icon
29
Repligen
RGEN
$6.64B
$3.68M 1.93%
27,500
-2,500
BIO icon
30
Bio-Rad Laboratories Class A
BIO
$7.52B
$3.08M 1.62%
11,000
-7,000
LH icon
31
Labcorp
LH
$22B
$2.87M 1.51%
+10,000
SEM icon
32
Select Medical
SEM
$2.02B
$2.25M 1.18%
175,000
-125,000
STVN icon
33
Stevanato
STVN
$3.75B
$2.19M 1.15%
+85,000
BRKR icon
34
Bruker
BRKR
$5.5B
$1.95M 1.02%
+60,000
GEHC icon
35
GE HealthCare
GEHC
$32.5B
$1.88M 0.99%
+25,000
ALGN icon
36
Align Technology
ALGN
$12.2B
– –
-15,000
ALNY icon
37
Alnylam Pharmaceuticals
ALNY
$43.9B
– –
-6,500
ARGX icon
38
argenx
ARGX
$45.3B
– –
-2,500
AVTR icon
39
Avantor
AVTR
$5.3B
– –
-225,000
BAX icon
40
Baxter International
BAX
$8.67B
– –
-75,000
COO icon
41
Cooper Companies
COO
$14B
– –
-30,000
GILD icon
42
Gilead Sciences
GILD
$173B
– –
-50,000
INSP icon
43
Inspire Medical Systems
INSP
$1.49B
– –
-10,000
MDGL icon
44
Madrigal Pharmaceuticals
MDGL
$12B
– –
-5,000
NVO icon
45
Novo Nordisk
NVO
$163B
– –
-100,000
RVTY icon
46
Revvity
RVTY
$9.8B
– –
-45,000
WAT icon
47
Waters Corp
WAT
$29.2B
– –
-18,000
1
2